Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Differentially expressed proteins in malignant and benign adrenocortical tumors.

Kjellin H, Johansson H, Höög A, Lehtiö J, Jakobsson PJ, Kjellman M.

PLoS One. 2014 Feb 3;9(2):e87951. doi: 10.1371/journal.pone.0087951. eCollection 2014.

2.

Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.

Soon PS, Gill AJ, Benn DE, Clarkson A, Robinson BG, McDonald KL, Sidhu SB.

Endocr Relat Cancer. 2009 Jun;16(2):573-83. doi: 10.1677/ERC-08-0237. Epub 2009 Feb 13.

3.

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E.

Cancer. 2011 Apr 15;117(8):1630-9. doi: 10.1002/cncr.25724. Epub 2010 Nov 8.

4.

Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.

Faria AM, Almeida MQ.

Mol Cell Endocrinol. 2012 Mar 31;351(1):52-7. doi: 10.1016/j.mce.2011.09.040. Epub 2011 Oct 14. Review.

PMID:
22019901
5.

Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane.

Stigliano A, Cerquetti L, Borro M, Gentile G, Bucci B, Misiti S, Piergrossi P, Brunetti E, Simmaco M, Toscano V.

Endocr Relat Cancer. 2008 Mar;15(1):1-10. doi: 10.1677/ERC-07-0003.

6.

Insulin-like growth factor system on adrenocortical tumorigenesis.

Ribeiro TC, Latronico AC.

Mol Cell Endocrinol. 2012 Mar 31;351(1):96-100. doi: 10.1016/j.mce.2011.09.042. Epub 2011 Oct 14.

PMID:
22019903
7.

Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, Soares IC, Starnes E, Thomas DG, Latronico AC, Giordano TJ, Hammer GD.

Am J Pathol. 2012 Sep;181(3):1017-33. doi: 10.1016/j.ajpath.2012.05.026. Epub 2012 Jul 15.

8.

Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.

Kiiveri S, Liu J, Arola J, Heikkilä P, Kuulasmaa T, Lehtonen E, Voutilainen R, Heikinheimo M.

Mol Cell Endocrinol. 2005 Apr 15;233(1-2):47-56.

PMID:
15767045
9.

Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Tan F, Jiang Y, Sun N, Chen Z, Lv Y, Shao K, Li N, Qiu B, Gao Y, Li B, Tan X, Zhou F, Wang Z, Ding D, Wang J, Sun J, Hang J, Shi S, Feng X, He F, He J.

Mol Cell Proteomics. 2012 Feb;11(2):M111.008821. doi: 10.1074/mcp.M111.008821. Epub 2011 Nov 7.

10.

Adrenocortical cancer and IGF2: is the game over or our experimental models limited?

Drelon C, Berthon A, Val P.

J Clin Endocrinol Metab. 2013 Feb;98(2):505-7. doi: 10.1210/jc.2012-3310. Epub 2013 Jan 7. No abstract available.

PMID:
23295462
11.

Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas.

Ilvesmäki V, Liu J, Heikkilä P, Kahri AI, Voutilainen R.

Horm Metab Res. 1998 Oct;30(10):619-23.

PMID:
9851669
12.

Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics.

Kim N, Lee Y, Kim H, Joo H, Youm JB, Park WS, Warda M, Cuong DV, Han J.

Proteomics. 2006 Feb;6(4):1237-49.

PMID:
16402359
13.

Classification of adrenal cortical tumors: what limits for the pathological approach?

Tissier F.

Best Pract Res Clin Endocrinol Metab. 2010 Dec;24(6):877-85. doi: 10.1016/j.beem.2010.10.011. Review.

PMID:
21115156
14.

Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.

Magro G, Esposito G, Cecchetto G, Dall'Igna P, Marcato R, Gambini C, Boldrini R, Collini P, D'Onofrio V, Salfi N, d'Amore E, Ferrari A, Bisogno G, Alaggio R.

Hum Pathol. 2012 Jan;43(1):31-9. doi: 10.1016/j.humpath.2011.04.016. Epub 2011 Aug 4.

PMID:
21820153
15.

Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.

de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, René-Corail F, Dousset B, Bertagna X, Clauser E, Bertherat J.

J Clin Oncol. 2009 Mar 1;27(7):1108-15. doi: 10.1200/JCO.2008.18.5678. Epub 2009 Jan 12.

PMID:
19139432
16.

Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker.

Skvortsov S, Schäfer G, Stasyk T, Fuchsberger C, Bonn GK, Bartsch G, Klocker H, Huber LA.

J Proteome Res. 2011 Jan 7;10(1):259-68. doi: 10.1021/pr100921j. Epub 2010 Nov 16.

PMID:
20977276
17.

Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.

Fottner Ch, Hoeflich A, Wolf E, Weber MM.

Horm Metab Res. 2004 Jun;36(6):397-405. Review.

PMID:
15241731
18.

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.

Meyer-Rochow GY, Jackson NE, Conaglen JV, Whittle DE, Kunnimalaiyaan M, Chen H, Westin G, Sandgren J, Stålberg P, Khanafshar E, Shibru D, Duh QY, Clark OH, Kebebew E, Gill AJ, Clifton-Bligh R, Robinson BG, Benn DE, Sidhu SB.

Endocr Relat Cancer. 2010 Aug 16;17(3):835-46. doi: 10.1677/ERC-10-0142. Print 2010 Sep.

19.

IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.

Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P, Perren A.

Histopathology. 2006 Sep;49(3):298-307.

PMID:
16918977
20.

Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation.

Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG.

Am J Surg Pathol. 1998 Jul;22(7):779-94. Erratum in: Am J Surg Pathol 1999 Jan;23(1):136.

PMID:
9669341

Supplemental Content

Support Center